Continuous-flow left ventricular assist device exchange: Clinical outcomes

Takeyoshi Ota, Halit Yerebakan, Hirokazu Akashi, Hiroo Takayama, Nir Uriel, Paolo C. Colombo, Ulrich P. Jorde, Yoshifumi Naka

Research output: Contribution to journalArticle

43 Citations (Scopus)

Abstract

Background A percentage of patients with a left ventricular assist device (LVAD) require device exchange. Although this is an important clinical entity, there are only a handful of relevant studies on this topic in the literature. Methods From 2004 to 2012, 30 device exchanges (HeartMate II to HeartMate II) were performed. Since June 2011, we have employed the subcostal approach for device exchange if indicated. Sixteen patients underwent device exchange through a subcostal approach (S group), whereas 14 patients had devices exchanged through a full sternotomy (F group). Pre- and post-operative data were retrospectively reviewed. Results There was no difference in baseline patient characteristics between the two groups. Overall, mean duration between primary surgery and device exchange was 425 ± 407 days. Surgical indications included device thrombus/hemolysis (N = 19), device malfunction (N = 9) and infection (N = 2). Cardiopulmonary bypass time was significantly shorter in the S group (S: 40 ± 23 minutes, F: 105 ± 84 minutes; p < 0.05), and post-operative bleeding within 24 hours after surgery was less in the S group (S: 362 ± 367 ml, F: 1,286 ± 971 ml; p < 0.05). Length of ICU stay was significantly shorter in the S group (S: 4.6 ± 1.8 days, F: 8.2 ± 4.9 days; p < 0.05). There was no difference in post-operative complications, except for prolonged intubation (F: N = 6 [43%], S: N = 1 [6.3%]; p < 0.05). There were 3 deaths in the F group and 0 in the S group, with no statistical difference (p = 0.09). Also, there was no significant difference in other outcomes, including transplantation, device explantation and ongoing LVAD support. Conclusions A subcostal approach may be preferred for HeartMate II device exchange if indicated.

Original languageEnglish (US)
Pages (from-to)65-70
Number of pages6
JournalJournal of Heart and Lung Transplantation
Volume33
Issue number1
DOIs
StatePublished - Jan 2014
Externally publishedYes

Fingerprint

Heart-Assist Devices
Equipment and Supplies
Sternotomy
Hemolysis
Cardiopulmonary Bypass
Intubation
Length of Stay
Thrombosis
Transplantation
Hemorrhage

Keywords

  • Device exchange
  • Device malfunction
  • Device thrombus
  • Left ventricular assist device
  • Minimally invasive
  • Subcostal approach

ASJC Scopus subject areas

  • Transplantation
  • Cardiology and Cardiovascular Medicine
  • Pulmonary and Respiratory Medicine
  • Surgery

Cite this

Ota, T., Yerebakan, H., Akashi, H., Takayama, H., Uriel, N., Colombo, P. C., ... Naka, Y. (2014). Continuous-flow left ventricular assist device exchange: Clinical outcomes. Journal of Heart and Lung Transplantation, 33(1), 65-70. https://doi.org/10.1016/j.healun.2013.07.003

Continuous-flow left ventricular assist device exchange : Clinical outcomes. / Ota, Takeyoshi; Yerebakan, Halit; Akashi, Hirokazu; Takayama, Hiroo; Uriel, Nir; Colombo, Paolo C.; Jorde, Ulrich P.; Naka, Yoshifumi.

In: Journal of Heart and Lung Transplantation, Vol. 33, No. 1, 01.2014, p. 65-70.

Research output: Contribution to journalArticle

Ota, T, Yerebakan, H, Akashi, H, Takayama, H, Uriel, N, Colombo, PC, Jorde, UP & Naka, Y 2014, 'Continuous-flow left ventricular assist device exchange: Clinical outcomes', Journal of Heart and Lung Transplantation, vol. 33, no. 1, pp. 65-70. https://doi.org/10.1016/j.healun.2013.07.003
Ota, Takeyoshi ; Yerebakan, Halit ; Akashi, Hirokazu ; Takayama, Hiroo ; Uriel, Nir ; Colombo, Paolo C. ; Jorde, Ulrich P. ; Naka, Yoshifumi. / Continuous-flow left ventricular assist device exchange : Clinical outcomes. In: Journal of Heart and Lung Transplantation. 2014 ; Vol. 33, No. 1. pp. 65-70.
@article{779e990cf4644abba1aa626dc8b323d4,
title = "Continuous-flow left ventricular assist device exchange: Clinical outcomes",
abstract = "Background A percentage of patients with a left ventricular assist device (LVAD) require device exchange. Although this is an important clinical entity, there are only a handful of relevant studies on this topic in the literature. Methods From 2004 to 2012, 30 device exchanges (HeartMate II to HeartMate II) were performed. Since June 2011, we have employed the subcostal approach for device exchange if indicated. Sixteen patients underwent device exchange through a subcostal approach (S group), whereas 14 patients had devices exchanged through a full sternotomy (F group). Pre- and post-operative data were retrospectively reviewed. Results There was no difference in baseline patient characteristics between the two groups. Overall, mean duration between primary surgery and device exchange was 425 ± 407 days. Surgical indications included device thrombus/hemolysis (N = 19), device malfunction (N = 9) and infection (N = 2). Cardiopulmonary bypass time was significantly shorter in the S group (S: 40 ± 23 minutes, F: 105 ± 84 minutes; p < 0.05), and post-operative bleeding within 24 hours after surgery was less in the S group (S: 362 ± 367 ml, F: 1,286 ± 971 ml; p < 0.05). Length of ICU stay was significantly shorter in the S group (S: 4.6 ± 1.8 days, F: 8.2 ± 4.9 days; p < 0.05). There was no difference in post-operative complications, except for prolonged intubation (F: N = 6 [43{\%}], S: N = 1 [6.3{\%}]; p < 0.05). There were 3 deaths in the F group and 0 in the S group, with no statistical difference (p = 0.09). Also, there was no significant difference in other outcomes, including transplantation, device explantation and ongoing LVAD support. Conclusions A subcostal approach may be preferred for HeartMate II device exchange if indicated.",
keywords = "Device exchange, Device malfunction, Device thrombus, Left ventricular assist device, Minimally invasive, Subcostal approach",
author = "Takeyoshi Ota and Halit Yerebakan and Hirokazu Akashi and Hiroo Takayama and Nir Uriel and Colombo, {Paolo C.} and Jorde, {Ulrich P.} and Yoshifumi Naka",
year = "2014",
month = "1",
doi = "10.1016/j.healun.2013.07.003",
language = "English (US)",
volume = "33",
pages = "65--70",
journal = "Journal of Heart and Lung Transplantation",
issn = "1053-2498",
publisher = "Elsevier USA",
number = "1",

}

TY - JOUR

T1 - Continuous-flow left ventricular assist device exchange

T2 - Clinical outcomes

AU - Ota, Takeyoshi

AU - Yerebakan, Halit

AU - Akashi, Hirokazu

AU - Takayama, Hiroo

AU - Uriel, Nir

AU - Colombo, Paolo C.

AU - Jorde, Ulrich P.

AU - Naka, Yoshifumi

PY - 2014/1

Y1 - 2014/1

N2 - Background A percentage of patients with a left ventricular assist device (LVAD) require device exchange. Although this is an important clinical entity, there are only a handful of relevant studies on this topic in the literature. Methods From 2004 to 2012, 30 device exchanges (HeartMate II to HeartMate II) were performed. Since June 2011, we have employed the subcostal approach for device exchange if indicated. Sixteen patients underwent device exchange through a subcostal approach (S group), whereas 14 patients had devices exchanged through a full sternotomy (F group). Pre- and post-operative data were retrospectively reviewed. Results There was no difference in baseline patient characteristics between the two groups. Overall, mean duration between primary surgery and device exchange was 425 ± 407 days. Surgical indications included device thrombus/hemolysis (N = 19), device malfunction (N = 9) and infection (N = 2). Cardiopulmonary bypass time was significantly shorter in the S group (S: 40 ± 23 minutes, F: 105 ± 84 minutes; p < 0.05), and post-operative bleeding within 24 hours after surgery was less in the S group (S: 362 ± 367 ml, F: 1,286 ± 971 ml; p < 0.05). Length of ICU stay was significantly shorter in the S group (S: 4.6 ± 1.8 days, F: 8.2 ± 4.9 days; p < 0.05). There was no difference in post-operative complications, except for prolonged intubation (F: N = 6 [43%], S: N = 1 [6.3%]; p < 0.05). There were 3 deaths in the F group and 0 in the S group, with no statistical difference (p = 0.09). Also, there was no significant difference in other outcomes, including transplantation, device explantation and ongoing LVAD support. Conclusions A subcostal approach may be preferred for HeartMate II device exchange if indicated.

AB - Background A percentage of patients with a left ventricular assist device (LVAD) require device exchange. Although this is an important clinical entity, there are only a handful of relevant studies on this topic in the literature. Methods From 2004 to 2012, 30 device exchanges (HeartMate II to HeartMate II) were performed. Since June 2011, we have employed the subcostal approach for device exchange if indicated. Sixteen patients underwent device exchange through a subcostal approach (S group), whereas 14 patients had devices exchanged through a full sternotomy (F group). Pre- and post-operative data were retrospectively reviewed. Results There was no difference in baseline patient characteristics between the two groups. Overall, mean duration between primary surgery and device exchange was 425 ± 407 days. Surgical indications included device thrombus/hemolysis (N = 19), device malfunction (N = 9) and infection (N = 2). Cardiopulmonary bypass time was significantly shorter in the S group (S: 40 ± 23 minutes, F: 105 ± 84 minutes; p < 0.05), and post-operative bleeding within 24 hours after surgery was less in the S group (S: 362 ± 367 ml, F: 1,286 ± 971 ml; p < 0.05). Length of ICU stay was significantly shorter in the S group (S: 4.6 ± 1.8 days, F: 8.2 ± 4.9 days; p < 0.05). There was no difference in post-operative complications, except for prolonged intubation (F: N = 6 [43%], S: N = 1 [6.3%]; p < 0.05). There were 3 deaths in the F group and 0 in the S group, with no statistical difference (p = 0.09). Also, there was no significant difference in other outcomes, including transplantation, device explantation and ongoing LVAD support. Conclusions A subcostal approach may be preferred for HeartMate II device exchange if indicated.

KW - Device exchange

KW - Device malfunction

KW - Device thrombus

KW - Left ventricular assist device

KW - Minimally invasive

KW - Subcostal approach

UR - http://www.scopus.com/inward/record.url?scp=84892181492&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84892181492&partnerID=8YFLogxK

U2 - 10.1016/j.healun.2013.07.003

DO - 10.1016/j.healun.2013.07.003

M3 - Article

C2 - 23937885

AN - SCOPUS:84892181492

VL - 33

SP - 65

EP - 70

JO - Journal of Heart and Lung Transplantation

JF - Journal of Heart and Lung Transplantation

SN - 1053-2498

IS - 1

ER -